Na Kang

机构：Chinese PLA General Hospital, Beijing Geriatric Hospital, Chinese Medical Center, Center for Life Sciences, Tsinghua University · ORCID：0000-0003-4771-0475

发表论文 14 篇 · 总被引 189 次 · h-index 7

代表论文

• Aberrant B-Cell Activation in Systemic Lupus Erythematosus (2022 · Kidney Diseases · 被引 35)
• MCT1-governed pyruvate metabolism is essential for antibody class-switch recombination through H3K27 acetylation (2024 · Nature Communications · 被引 32)
• Protocol for colitis-associated colorectal cancer murine model induced by AOM and DSS (2023 · STAR Protocols · 被引 29)
• Ion channel TRPV2 is critical in enhancing B cell activation and function (2024 · The Journal of Experimental Medicine · 被引 24)
• TNF inhibitors target a mevalonate metabolite/TRPM2/calcium signaling axis in neutrophils to dampen vasculitis in Behçet’s disease (2024 · Nature Communications · 被引 21)
• Metabolite‐derived damage‐associated molecular patterns in immunological diseases (2023 · FEBS Journal · 被引 16)